- Home
- MLYS vs CYH Comparison
MLYS vs CYH Comparison
Compare MLYS & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- CYH
- Stock Information
- Founded
- MLYS 2019
- CYH 1985
- Country
- MLYS United States
- CYH United States
- Employees
- MLYS N/A
- CYH N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- MLYS Health Care
- CYH Health Care
- Exchange
- MLYS Nasdaq
- CYH Nasdaq
- Market Cap
- MLYS 526.1M
- CYH 440.4M
- IPO Year
- MLYS 2023
- CYH 1991
- Fundamental
- Price
- MLYS $10.21
- CYH $3.20
- Analyst Decision
- MLYS Strong Buy
- CYH Hold
- Analyst Count
- MLYS 2
- CYH 6
- Target Price
- MLYS $30.00
- CYH $4.40
- AVG Volume (30 Days)
- MLYS 263.5K
- CYH 1.9M
- Earning Date
- MLYS 03-20-2025
- CYH 02-18-2025
- Dividend Yield
- MLYS N/A
- CYH N/A
- EPS Growth
- MLYS N/A
- CYH N/A
- EPS
- MLYS N/A
- CYH N/A
- Revenue
- MLYS N/A
- CYH $12,551,000,000.00
- Revenue This Year
- MLYS N/A
- CYH $1.16
- Revenue Next Year
- MLYS N/A
- CYH $1.18
- P/E Ratio
- MLYS N/A
- CYH N/A
- Revenue Growth
- MLYS N/A
- CYH 0.81
- 52 Week Low
- MLYS $8.58
- CYH $2.51
- 52 Week High
- MLYS $16.91
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- MLYS 44.53
- CYH 45.86
- Support Level
- MLYS $9.57
- CYH $3.20
- Resistance Level
- MLYS $10.79
- CYH $3.39
- Average True Range (ATR)
- MLYS 0.64
- CYH 0.16
- MACD
- MLYS 0.11
- CYH 0.02
- Stochastic Oscillator
- MLYS 63.98
- CYH 47.14
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.